A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Jury finds in favor of GlaxoSmithKline in Zantac trial in Illinois, ruling that company is not liable for plaintiff's colorectal cancer
Published: May 24, 2024 by Radiocor World English Newswire (Italy)
Bristol Myers Squibb collaborates with ATOM Coalition to expand access to Opdivo immuno-oncology therapy in select countries; Bristol Myers' 10-year ASPIRE strategy aims to reach 200,000 patients in low- and middle-income countries by 2033
Published: May 22, 2024 by Business Wire
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
Published: May 20, 2024 by Sanofi SA
AstraZeneca ordered to pay US$107.5M to Pfizer for infringing two patents with its oncology med Tagrisso; Pfizer subsidiary Wyeth and Puma Biotechnology first sued AstraZeneca in 2021
Published: May 20, 2024 by FiercePharma
AstraZeneca to pay $107.5M for cancer drug patent infringement
Published: May 20, 2024 by Becker's Hospital Review

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count